(EBR) Centrais Electricas - Ratings and Ratios
Electricity, Transmission, Hydroelectric, Nuclear, Solar
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 31.3% |
| Value at Risk 5%th | 51.2% |
| Relative Tail Risk | -0.53% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.34 |
| Alpha | 92.75 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.521 |
| Beta | 0.480 |
| Beta Downside | 0.469 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.66% |
| Mean DD | 16.25% |
| Median DD | 16.87% |
Description: EBR Centrais Electricas October 16, 2025
Centrais Elétricas Brasileiras S.A. (Eletrobrás) is Brazil’s state-controlled utility that produces, transmits, and markets electricity across the country, operating a diversified mix of hydro, thermoelectric, nuclear, wind, and solar assets.
Through its subsidiaries, Eletrobrás owns 44 hydroelectric plants totaling 42,293.5 MW of installed capacity and manages roughly 66,540 km of high-voltage transmission lines, positioning it as the largest grid operator in Brazil.
Key drivers of Eletrobrás’s outlook include: (1) Brazil’s electricity demand is expected to grow ~2.5 % annually through 2028, fueled by industrial expansion and rising residential consumption; (2) the company’s recent 1.2 GW addition of wind and solar capacity in 2023 improves its renewable share to ~23 % of total generation, aligning with the country’s 2030 decarbonization targets; and (3) a high debt-to-EBITDA ratio (~4.5×) reflects the capital-intensive nature of its transmission network, making credit conditions and government fiscal policy critical to financial flexibility.
For a deeper, data-driven assessment of EBR’s valuation metrics and scenario analysis, you may find the research tools on ValueRay useful.
EBR Stock Overview
| Market Cap in USD | 24,817m |
| Sub-Industry | Electric Utilities |
| IPO / Inception | 2008-11-07 |
| Return 12m vs S&P 500 | 85.0% |
| Analyst Rating | 4.67 of 5 |
EBR Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 8.79% |
| Yield on Cost 5y | 21.19% |
| Yield CAGR 5y | -8.02% |
| Payout Consistency | 55.7% |
| Payout Ratio | 6.6% |
EBR Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 14.70% |
| CAGR/Max DD Calmar Ratio | 0.38 |
| CAGR/Mean DD Pain Ratio | 0.90 |
| Current Volume | 1036.3k |
| Average Volume | 1995.5k |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (-6.02b TTM) > 0 and > 6% of Revenue (6% = 2.56b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 3.64pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 58.78% (prev 74.37%; Δ -15.58pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 16.76b > Net Income -6.02b (YES >=105%, WARN >=100%) |
| Net Debt (56.82b) to EBITDA (2.96b) ratio: 19.18 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.92 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.25b) change vs 12m ago -1.22% (target <= -2.0% for YES) |
| Gross Margin 81.62% (prev 80.74%; Δ 0.89pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 15.61% (prev 13.61%; Δ 2.00pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.10 (EBITDA TTM 2.96b / Interest Expense TTM 8.16b) >= 6 (WARN >= 3) |
Altman Z'' 1.67
| (A) 0.09 = (Total Current Assets 52.37b - Total Current Liabilities 27.31b) / Total Assets 266.50b |
| (B) 0.12 = Retained Earnings (Balance) 32.79b / Total Assets 266.50b |
| (C) -0.00 = EBIT TTM -826.5m / Avg Total Assets 273.15b |
| (D) 0.64 = Book Value of Equity 101.08b / Total Liabilities 157.16b |
| Total Rating: 1.67 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 55.31
| 1. Piotroski 4.50pt |
| 2. FCF Yield 7.66% |
| 3. FCF Margin 33.17% |
| 4. Debt/Equity 0.69 |
| 5. Debt/Ebitda 19.18 |
| 6. ROIC - WACC (= -6.48)% |
| 7. RoE -5.11% |
| 8. Rev. Trend 56.35% |
| 9. EPS Trend -11.13% |
What is the price of EBR shares?
Over the past week, the price has changed by -2.78%, over one month by +12.93%, over three months by +48.10% and over the past year by +105.82%.
Is EBR a buy, sell or hold?
- Strong Buy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the EBR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12.4 | 11.2% |
| Analysts Target Price | 12.4 | 11.2% |
| ValueRay Target Price | 13.4 | 20.7% |
EBR Fundamental Data Overview November 15, 2025
P/E Trailing = 20.4259
P/E Forward = 17.4825
P/S = 0.582
P/B = 1.2532
Beta = 0.303
Revenue TTM = 42.64b BRL
EBIT TTM = -826.5m BRL
EBITDA TTM = 2.96b BRL
Long Term Debt = 59.63b BRL (from longTermDebt, last quarter)
Short Term Debt = 15.04b BRL (from shortTermDebt, last quarter)
Debt = 75.32b BRL (from shortLongTermDebtTotal, last quarter)
Net Debt = 56.82b BRL (from netDebt column, last quarter)
Enterprise Value = 184.75b BRL (134.08b + Debt 75.32b - CCE 24.65b)
Interest Coverage Ratio = -0.10 (Ebit TTM -826.5m / Interest Expense TTM 8.16b)
FCF Yield = 7.66% (FCF TTM 14.15b / Enterprise Value 184.75b)
FCF Margin = 33.17% (FCF TTM 14.15b / Revenue TTM 42.64b)
Net Margin = -14.11% (Net Income TTM -6.02b / Revenue TTM 42.64b)
Gross Margin = 81.62% ((Revenue TTM 42.64b - Cost of Revenue TTM 7.84b) / Revenue TTM)
Gross Margin QoQ = 40.81% (prev 47.88%)
Tobins Q-Ratio = 0.69 (Enterprise Value 184.75b / Total Assets 266.50b)
Interest Expense / Debt = 2.80% (Interest Expense 2.11b / Debt 75.32b)
Taxrate = -4.33% (negative due to tax credits) (226.2m / -5.22b)
NOPAT = -862.3m (EBIT -826.5m * (1 - -4.33%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 1.92 (Total Current Assets 52.37b / Total Current Liabilities 27.31b)
Debt / Equity = 0.69 (Debt 75.32b / totalStockholderEquity, last quarter 109.29b)
Debt / EBITDA = 19.18 (Net Debt 56.82b / EBITDA 2.96b)
Debt / FCF = 4.02 (Net Debt 56.82b / FCF TTM 14.15b)
Total Stockholder Equity = 117.84b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.26% (Net Income -6.02b / Total Assets 266.50b)
RoE = -5.11% (Net Income TTM -6.02b / Total Stockholder Equity 117.84b)
RoCE = -0.47% (EBIT -826.5m / Capital Employed (Equity 117.84b + L.T.Debt 59.63b))
RoIC = -0.45% (negative operating profit) (NOPAT -862.3m / Invested Capital 192.17b)
WACC = 6.03% (E(134.08b)/V(209.40b) * Re(7.78%) + D(75.32b)/V(209.40b) * Rd(2.80%) * (1-Tc(-0.04)))
Discount Rate = 7.78% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.35%
[DCF Debug] Terminal Value 81.35% ; FCFE base≈10.35b ; Y1≈12.70b ; Y5≈21.39b
Fair Price DCF = 184.3 (DCF Value 364.21b / Shares Outstanding 1.98b; 5y FCF grow 24.25% → 3.0% )
EPS Correlation: -11.13 | EPS CAGR: -40.86% | SUE: -0.51 | # QB: 0
Revenue Correlation: 56.35 | Revenue CAGR: 3.88% | SUE: 0.00 | # QB: 0
Additional Sources for EBR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle